AMA Update

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.

AMA Update 290: Naloxone: FDA approves over-the-counter Narcan nasal spray, with Bobby Mukkamala, MD

Bobby Mukkamala, MD, chair of the AMA Substance Use and Pain Care Task Force, joins to discuss what FDA’s recent approval of OTC naloxone means for doctors and patients—as well as how to administer Narcan in an emergency. The life-saving medication can reverse an overdose from fentanyl, oxycodone and other opioids. American Medical Association CXO Todd Unger hosts. Visit https://end-overdose-epidemic.org for more information on AMA’s efforts to end the overdose epidemic.

 

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.